76 related articles for article (PubMed ID: 22574520)
1. 5-arylidene(thio)hydantoin derivatives as modulators of cancer efflux pump.
Handzlik J; Spengler G; Mastek B; Dela A; Molnar J; Amaral L; Kieć-Kononowicz K
Acta Pol Pharm; 2012; 69(1):149-56. PubMed ID: 22574520
[No Abstract] [Full Text] [Related]
2. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in vitro.
Parekh S; Bhavsar D; Savant M; Thakrar S; Bavishi A; Parmar M; Vala H; Radadiya A; Pandya N; Serly J; Molnár J; Shah A
Eur J Med Chem; 2011 May; 46(5):1942-8. PubMed ID: 21396744
[TBL] [Abstract][Full Text] [Related]
3. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Pajak B; Molnar J; Engi H; Orzechowski A
In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
[TBL] [Abstract][Full Text] [Related]
4. Menadione serves as a substrate for P-glycoprotein: implication in chemosensitizing activity.
Oh SJ; Han HK; Kang KW; Lee YJ; Lee MY
Arch Pharm Res; 2013 Apr; 36(4):509-16. PubMed ID: 23435914
[TBL] [Abstract][Full Text] [Related]
5. Ceramide glycosylation potentiates cellular multidrug resistance.
Liu YY; Han TY; Giuliano AE; Cabot MC
FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
[TBL] [Abstract][Full Text] [Related]
6. Activity of fourteen new hydantoin compounds on the human ABCB1 efflux pump.
Martins A; Dymek A; Handzlik J; Spengler G; Armada A; Molnar J; Kiéc-Kononowicz K; Amaral L
In Vivo; 2012; 26(2):293-7. PubMed ID: 22351672
[TBL] [Abstract][Full Text] [Related]
7. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE
Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041
[TBL] [Abstract][Full Text] [Related]
8. Modulation of multidrug efflux pump activity by new hydantoin derivatives on colon adenocarcinoma cells without inducing apoptosis.
Spengler G; Handzlik J; Ocsovszki I; Viveiros M; Kiec-Kononowicz K; Molnar J; Amaral L
Anticancer Res; 2011 Oct; 31(10):3285-8. PubMed ID: 21965738
[TBL] [Abstract][Full Text] [Related]
9. Constituents of Carpobrotus edulis inhibit P-glycoprotein of MDR1-transfected mouse lymphoma cells.
Martins A; Vasas A; Schelz Z; Viveiros M; Molnár J; Hohmann J; Amaral L
Anticancer Res; 2010 Mar; 30(3):829-35. PubMed ID: 20393003
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors.
Voigt B; Coburger C; Monár J; Hilgeroth A
Bioorg Med Chem; 2007 Aug; 15(15):5110-3. PubMed ID: 17533131
[TBL] [Abstract][Full Text] [Related]
11. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance reversal activity of permethyl ningalin B amide derivatives.
Tao H; Hwang I; Boger DL
Bioorg Med Chem Lett; 2004 Dec; 14(24):5979-81. PubMed ID: 15546712
[TBL] [Abstract][Full Text] [Related]
13. The lipophilicity estimation of 5-arylidene derivatives of (2-thio)hydantoin with antimycobacterial activity.
Lazewska D; Maludziński P; Szymańska E; Kieć-Kononowicz K
Biomed Chromatogr; 2007 Mar; 21(3):291-8. PubMed ID: 17221916
[TBL] [Abstract][Full Text] [Related]
14. Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
Xi GM; Sun B; Jiang HH; Kong F; Yuan HQ; Lou HX
Bioorg Med Chem; 2010 Sep; 18(18):6725-33. PubMed ID: 20724170
[TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
16. An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells.
Żesławska E; Kucwaj-Brysz K; Kincses A; Spengler G; Szymańska E; Czopek A; Marć MA; Kaczor A; Nitek W; Domínguez-Álvarez E; Latacz G; Kieć-Kononowicz K; Handzlik J
Bioorg Chem; 2021 Apr; 109():104735. PubMed ID: 33640632
[TBL] [Abstract][Full Text] [Related]
17. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.
Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ
Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007
[TBL] [Abstract][Full Text] [Related]
18. Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.
Fruttero R; Crosetti M; Chegaev K; Guglielmo S; Gasco A; Berardi F; Niso M; Perrone R; Panaro MA; Colabufo NA
J Med Chem; 2010 Aug; 53(15):5467-75. PubMed ID: 20684594
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr+cells.
Varga A; Aki-Sener E; Yalcin I; Temiz-Arpaci O; Tekiner-Gulbas B; Cherepnev G; Molnar J
In Vivo; 2005; 19(6):1087-91. PubMed ID: 16277027
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
